Developing a Novel Small Molecule Oxysterol as a Potent Inhibitor of TGF-β
Time: 2:30 pm
day: Conference Day Two
Details:
- Utilizing Oxy210 as a poly-pharmacological drug candidate to target 3 main signaling pathways in fibroblasts and other cells involved in fibrosis and inflammation
- Demonstrating the intact TGF-β-mediated immune cell responses upon Oxy210 treatment
- Evaluating the therapeutic effects of Oxy210 on chronic inflammatory diseases associated with metabolic dysfunction
New Data!
